TI
GBT

Trexquant Investment’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Trexquant Investment’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6,672
Closed -$213K – 1957
2022
Q2 		$213K Sell
6,672
-4,588
-41% -$134K 0.01% 1324
2022
Q1 		$390K Sell
11,260
-15,662
-58% -$468K 0.02% 885
2021
Q4 		$788K Buy
26,922
+18,779
+231% +$582K 0.05% 467
2021
Q3 		$207K Buy
+8,143
New +$239K 0.02% 949
2021
Q2 		– Sell
-7,947
Closed -$324K – 1637
2021
Q1 		$324K Sell
7,947
-7,496
-49% -$345K 0.03% 709
2020
Q4 		$669K Buy
15,443
+3,434
+29% +$169K 0.07% 358
2020
Q3 		$662K Sell
12,009
-1,586
-12% -$101K 0.04% 566
2020
Q2 		$858K Buy
13,595
+4,806
+55% +$330K 0.06% 447
2020
Q1 		$449K Buy
+8,789
New +$589K 0.03% 697
2019
Q2 		– Sell
-11,279
Closed -$597K – 1229
2019
Q1 		$597K Buy
+11,279
New +$554K 0.04% 539
2018
Q4 		– Sell
-34,966
Closed -$1.33M – 1392
2018
Q3 		$1.33M Buy
34,966
+30,540
+690% +$1.35M 0.1% 282
2018
Q2 		$200K Sell
4,426
-26,759
-86% -$1.22M 0.01% 792
2018
Q1 		$1.51M Buy
+31,185
New +$1.74M 0.11% 310
2017
Q4 		– Sell
-6,518
Closed -$202K – 1310
2017
Q3 		$202K Buy
+6,518
New +$183K 0.05% 640

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Trexquant Investment's GBT Position: Q3 2022 in Review

Trexquant Investment sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2022, closing a stake of 6,672 shares — an estimated $213K sold.

Trexquant Investment first reported a position in GBT in Q3 2017 and held it in 14 quarters. The position peaked at $1.51M in Q1 2018. 247 funds tracked by Wall St. Rank hold GBT as of Q3 2022.

  • Trexquant Investment reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2022 after selling out during the quarter.
  • Trexquant Investment sold 6,672 Global Blood Therapeutics, Inc. shares in Q3 2022, an estimated $213K.
  • Trexquant Investment first reported a position in Global Blood Therapeutics, Inc. in Q3 2017 and held it in 14 quarters.
  • Trexquant Investment's Global Blood Therapeutics, Inc. position peaked at $1.51M in Q1 2018.
  • 247 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2022.

Based on Trexquant Investment's 13F filing for Q3 2022, filed 14 Nov 2022.